IMNM Immunome Inc Total Asset Value of Company
Immunome, Inc. (IMNM) specializes in antibody discovery for cancer treatment, attracting experts through advanced R&D tools and a stock option system. This price chart reflects a market trend for the asset with total assets at 430.83. Investors value Immunome, Inc. (IMNM) as a bold innovator with an impeccable reputation within the scientific community. Research stability is ensured by strict temperature controls during the transport of biological materials.
Analytical breakdowns and data insights for company Immunome Corp (IMNM)
- price and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Immunome, Inc.|IMNM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Immunome Bio|IMNM - Company Aggregate Debts|Debts to Book Capitalization Immunome Bio|IMNM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Immunome|Interim Coverage Ratio immunome.com
- net income and valuation multiples indicators:
Fundamental valuation:Immunome, Inc.
Total assets accumulate the value of all company resources, combining equity and liabilities to assess the scale of the business. By analyzing the current level of total assets, calculated reversely via ROA for real-time monitoring, an investor can see the expansion dynamics of the Immunome, Inc. (IMNM) base, where financial stability is maintained through strategic partnerships in oncology therapy development until positive cash flow is achieved.
Key competitors
Cumulative Company Assets argenx.com|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|Rigel Pharmaceuticals Inc - Company Total Assets|Company Total Asset Base AnaptysBio Inc. ANAB|Astria Therapeutics (ATXS) - Aggregate Company Assets|Cumulative Company Assets engene.com|Aggregate Company Assets RAPT Therapeutics|Cumulative Company Assets Aerovate (JBIO)|Cumulative Company Assets ACRS (Aclaris)|Company Total Assets Kyverna Therapeutics, Inc (KYTX)|Aggregate Company Assets Tiziana Life Sciences TLSA|CABA: Total Business Assets|VTYX - Aggregate Company Assets|Company Assets Theratechnologies, Inc.|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|Cumulative Company Assets Eledon Pharmaceuticals, Inc|AGEN (Agenus) - Company Total Assets|Company Assets climbbio.com CLYM|Cumulative Company Assets ZURA (Zura Bio)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Company Total Assets ADAG (Adagene Inc.)|Company Total Asset Base ImageneBio (IMA)|STTK - Aggregate Company Assets|EQ (Equillium, Inc.) - Total Business Assets|CNTB: Company Total Assets|Cumulative Company Assets Immunic|Cumulative Company Assets ATRA|InflaRx GmbH (IFRX) - Company Total Asset Base|Company Total Assets XFOR|Company Total Asset Base adicetbio.com|Aggregate Company Assets Celularity CELU|INMB - Cumulative Company Assets|BRNS - Aggregate Company Assets|KZR (Kezar Life Sciences Inc) - Total Business Assets|SAB Biotherapeutics (SABS) - Aggregate Company Assets|Cumulative Company Assets akaritx.com|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp - Total Asset Value of Company|Company Total Assets GOVX|EDSA (Edesa Biotech Corp) - Aggregate Asset Value|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB - Aggregate Company Assets|Aggregate Asset Value BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Aggregate Company Assets|Cumulative Company Assets Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Cumulative Company Assets GRI (GRI Bio)|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Company Total Assets HIND (ReShape Lifesciences)|Company Total Asset Base Revelation Biosciences Corp (REVB)|INDP - Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|Cumulative Company Assets ALLK|Company Total Assets HOOKIPA|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|iteostherapeutics.com - Total Business Assets|Company Total Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc (TCBP) - Company Assets|Third Harmonic Bio, Inc - Company Total Assets